<DOC>
	<DOCNO>NCT00829569</DOCNO>
	<brief_summary>The purpose experimental study investigate whether acute lipid infusion add marine n-3 fatty acid produce effect insulin sensitivity subject type 2 diabetes , compare acute lipid infusion without marine n-3 fatty acid . Furthermore effect intermediary metabolism test .</brief_summary>
	<brief_title>n-3 Fatty Acid Infusion Type 2 Diabetes</brief_title>
	<detailed_description>Evidence indicate n-3 fatty acid exert several beneficial effect . However , effect marine n-3 fatty acid intermediary metabolism completely elucidate . In previous study high intake marine n-3 fatty acid 9 wk demonstrate reduced insulin sensitivity alter proportion carbohydrate vs. fat oxidation subject type 2 diabetes . These result question use high dos n-3 supplement type 2 diabetes . It known extent effect type 2 diabetes reproduce intravenous administration n-3 fatty acid and/or whether short term intravenous administration effect .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Soybean oil , phospholipid emulsion</mesh_term>
	<criteria>Type 2 diabetes define clinical criterion absence antibody glutamic acid decarboxylase . HbA1c 5,5 8,5 % Blood pressure ≤ 170 mm Hg systolic and/or ≤ 105 mm Hg diastolic insulin treatment hypertriglyceridemia ( &gt; 2,1 mmol/l TG ) proliferative retinopathy , renal insufficiency ( SeCreatinine &gt; 150 μmol/l ) alcoholism , congestive heart failure serious disease affect possibility subject participate supplement fish oil marine n3 fatty acid last 6 month baseline Dicumarol treatment allergy soya , fish egg pregnancy lactation smoking</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Intralipid</keyword>
	<keyword>Omegaven</keyword>
	<keyword>fish oil</keyword>
	<keyword>hyperinsulinemic isoglycemic clamp</keyword>
	<keyword>C-peptide glucagon test</keyword>
	<keyword>indirect calorimetry</keyword>
	<keyword>F2-isoprostanes</keyword>
</DOC>